logo
Share SHARE
FONT-SIZE Plus   Neg

Beware Of Tainted Weight Loss Pills, Warns FDA

Beware Of Tainted Weight Loss Pills, Warns FDA

Consumers are advised not to purchase or use "Japan Rapid Weight Loss Diet Pills", a product for weight loss, as they contain a cancer-causing agent, warns the FDA.

The "Japan Rapid Weight Loss Pills", which are available in three different colors namely, green, yellow and blue, are sold on various websites, such as www.ebay.com, and distributed by a company called Xiushentang.

A laboratory analysis by the FDA has confirmed that these weight loss diet pills contain undeclared Phenolphthalein and Sibutramine.

Phenolphthalein is a chemical capable of potentially damaging or even causing mutations in a person's DNA. The FDA has classified Phenolphthalein as "not generally recognized as safe and effective."

Sibutramine is a substance known to substantially increase blood pressure and/or pulse rate in some patients.

Remember, Abbott Laboratories' obesity drug Meridia, which was pulled off the market in October 2010 due to increased risk of heart attack and stroke? The active ingredient in Meridia was also Sibutramine.

The FDA in a statement said that consumers should stop using these products immediately and throw them away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT